Ratings by Citi (Brendan Digan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Buy (N/A) |
20.41 (20.20) |
-1.03% | Details | |
| 7/30/2026 | Sotera Health | SHC | New Coverage | Buy (N/A) |
17.53 (18.22) |
3.94% | Details | |
| 7/30/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
41.81 (44.75) |
7.03% | Details | |
| 7/30/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
253.82 (410.35) |
61.67% | Details | |
| 7/30/2026 | ICON plc | ICLR | New Coverage | Neutral (N/A) |
178.18 (162.05) |
-9.05% | Details | |
| 7/30/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
144.07 (177.80) |
23.41% | Details | |
| 7/30/2026 | Fortrea | FTRE | New Coverage | Buy (N/A) |
20.40 (20.00) |
-1.96% | Details | |
| 7/30/2026 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
15.59 (28.30) |
81.53% | Details | |
| 7/30/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
61.74 (63.24) |
2.43% | Details | |
| 7/30/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
46.32 (93.50) |
101.86% | Details |
